Cited by 232Dementia and Cognitive Impairment ResearchNeurological Disease Mechanisms and TreatmentsNeuroprotection in Cerebral Ischemia

The DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index.

Emerging Therapies for Vascular Dementia and Vascular Cognitive Impairment

Erkinjuntti, Timo, Román, Gustavo, Gauthier, Serge, Feldman, Howard, Rockwood, Kenneth·2004·Stroke

DOI 10.1161/01.str.0000120731.88236.33

Open this paper in CoChat — free account

Abstract

Background— Cerebrovascular disease (CVD) and ischemic brain injury secondary to cardiovascular disease are common causes of dementia and cognitive decline in the elderly. CVD also contributes to cognitive loss in Alzheimer disease (AD). Summary— Progress in understanding vascular cognitive impairment (VCI) and vascular dementia (VaD) has resulted in promising symptomatic and preventive treatments. Cholinergic deficits in VaD due to ischemia of basal forebrain nuclei and cholinergic pathways can be treated with cholinesterase inhibitors used in AD. Controlled clinical trials with donepezil and galantamine in patients with VaD, as well as in patients with AD plus CVD, have demonstrated improvement in cognition, behavior, and activities of daily living. The N -methyl- d -aspartate receptor antagonist memantine stabilized progression of VaD compared with placebo. Primary and secondary stroke prevention, in particular with control of hypertension and hyperlipidemia, can decrease VaD incidence. Conclusions— From a public health viewpoint, recognition of VCI before the development of dementia and correction of vascular burden on the brain may lead to a global decrease of incident dementia.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1161/01.str.0000120731.88236.33

Cites

85 of 85 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia
Cummings, J. L., Mega, M., Gray, K., Rosenberg-Thompson, S., Carusi, D. A., & Gornbein, J. (1994) · Neurology · doi:10.1212/wnl.44.12.2308 · Cited by 7,568
Vascular dementia: Diagnostic criteria for research studies: Report of the NINDS‐AIREN International Workshop*
Román, G. C., Tatemichi, T. K., Erkinjuntti, T., Cummings, J. L., Masdeu, J. C., Garcia, J. H., Amaducci, L., Orgogozo, J.-M., Brun, A., Hofman, A., et al. (1993) · Neurology · doi:10.1212/wnl.43.2.250 · Cited by 4,921
Self-citation
The Association Between Quantitative Measures of Dementia and of Senile Change in the Cerebral Grey Matter of Elderly Subjects
Blessed, G., Tomlinson, B. E., & Roth, M. (1968) · British Journal of Psychiatry · doi:10.1192/bjp.114.512.797 · Cited by 4,117
. Cerebral blood flow in dementia.
Hachinski, V. C., Iliff, L. D., Zilhka, E., Du Boulay, G. H., McAllister, V. L., Marshall, J., Russell, R. W. R., & Symon, L. (1975) · Archives of Neurology · doi:10.1001/archneur.1975.00490510088009 · Cited by 3,186
Brain Infarction and the Clinical Expression of Alzheimer Disease<subtitle>The Nun Study</subtitle>
Snowdon, D. A. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03540340047031 · Cited by 1,590
Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales
(2001) · The Lancet · doi:10.1016/s0140-6736(00)03589-3 · Cited by 1,338
Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers
Chui, H. C., Victoroff, J. I., Margolin, D., Jagust, W., Shankle, R., & Katzman, R. (1992) · Neurology · doi:10.1212/wnl.42.3.473 · Cited by 1,201
Vascular Cognitive Impairment
O'Brien, J. T., Erkinjuntti, T., Reisberg, ‌., Román, G. C., Pantoni, L., Bowler, J., Ballard, C., DeCarli, C., Gorelick, P., Rockwood, K., et al. (2014) · International Journal of Stroke · doi:10.1111/ijs.12374_18 · Cited by 1,165
Self-citation
Vascular cognitive impairment
O'Brien, J. T., Erkinjuntti, T., Reisberg, B., Roman, G., Sawada, T., Pantoni, L., Bowler, J. V., Ballard, C., DeCarli, C., Gorelick, P. B., et al. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00305-3 · Cited by 1,139
Self-citation
Subcortical ischaemic vascular dementia
Román, G. C., Erkinjuntti, T., Wallin, A., Pantoni, L., & Chui, H. C. (2002) · The Lancet Neurology · doi:10.1016/s1474-4422(02)00190-4 · Cited by 1,067
Self-citation

Show all 85 references

Research works printed but not linked: 11

10.1161/str.28.4.729 · DOI
Erkinjuntti T, Hachinski VC. Rethinking vascular dementia. Cerebrovasc Dis. 1993; 3: 3–23.
10.1161/str.31.12.2952 · DOI
10.1161/str.33.3.862 · DOI
10.1161/str.27.8.1283 · DOI
Ferris S Gauthier S. Cognitive outcome measures in vascular dementia. In: Erkinjuntii T Gauthier S eds. Vascular Cognitive Impairment. London UK: Martin Duniz Ltd; 2002: 395–400.
Chui E Yastrubetskaya O Williams M. Pharmacotherapy of mood and behavior symptoms. In: Erkinjuntti T Gauthier S eds. Vascular Cognitive Impairment. London UK: Martin Duniz Ltd; 2002: 597–605.
Gauthier S Gélinas I. Evaluation of daily activities in vascular cognitive impairment. In: Erkinjuntti T Gauthier S eds. Vascular Cognitive Impairment. London UK: Martin Duniz Ltd; 2002: 411–416.
Görtelmeyer R, Erbler H. Memantine in treatment of mild to moderate dementia syndrome. Drug Res. 1992; 42: 904–912.
Court JA Perry EK Kalaria RN. Neurotransmitter control of the cerebral vasculature and abnormalities in vascular dementia. In: Erkinjuntti T Gauthier S eds. Vascular Cognitive Impairment. London UK: Martin Duniz Ltd; 2002: 167–185.
Rockwood K. Clinical meaningfulness in relation to the size of the treatment effect of cholinesterase inhibition on cognition in Alzheimer’s disease. Neurobiol Aging. 2002; 23: S168, 628.

Sorted by citations

Items 101–200 of 232

Relief of carotid stenosis improves impaired cognition in a rat model of chronic cerebral hypoperfusion
Duan, W., Zhang, C., Zheng, J., Gui, L., Huang, H., & Chen, K. (2011) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-2011-1843 · Cited by 15
Effect of fingolimod on oligodendrocyte maturation under prolonged cerebral hypoperfusion
Yasuda, K., Maki, T., Saitô, S., Yamamoto, Y., Kinoshita, H., Choi, Y. K., Arumugam, T. V., Lim, Y.-A., Chen, C., Wong, P. T.-H., et al. (2019) · Brain Research · doi:10.1016/j.brainres.2019.06.013 · Cited by 15
Preliminary findings on the reliability and validity of the Cantonese Birmingham Cognitive Screen in patients with acute ischemic stroke
Chen, H., Pan, X., Bickerton, W., Lau, J. K. L., Kong, A. P., Rotshtein, P., Guo, A., Hu, J., & Humphreys, G. W. (2015) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s85698 · Cited by 15
Effects of electroacupuncture on the expression of p70 ribosomal protein S6 kinase and ribosomal protein S6 in the hippocampus of rats with vascular dementia.
Zhu, Y., Wang, X., Ye, X., Gao, C., & Wang, W. (2012) · Europe PMC (PubMed Central) · doi:10.3969/j.issn.1673-5374.2012.03.009 · Cited by 15
Could Cholinesterase Inhibitors and Memantine Alleviate HIV Dementia?
Alisky, J. M. (2004) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200501010-00021 · Cited by 15
Mild Cognitive Impairment
(2006) · Wiley eBooks · doi:10.1002/9780470041000.cedt079 · Cited by 15
Neuroprotection in Vascular Dementia
Martínez‐Vila, E., Murie-Fernández, M., Pérez‐Larraya, J. G., & Irimia, P. (2006) · Cerebrovascular Diseases · doi:10.1159/000091710 · Cited by 15
Vascular cognitive impairment: Current concepts and Indian perspective
Alladi, S., Kaul, S., & Mekala, S. (2010) · Annals of Indian Academy of Neurology · doi:10.4103/0972-2327.74254 · Cited by 13
Psychotropic Medication and Functional Recovery following Cortical Stroke in Aged Rats
Zhao, C. (2005) · Cited by 13
Alizarin attenuates oxidative stress-induced mitochondrial damage in vascular dementia rats by promoting TRPM2 ubiquitination and proteasomal degradation via Smurf2
Pan, G., Liu, Y., Qi, M.-X., Guo, Y., Shao, Z.-L., Liu, H., Qian, Y., Guo, S., Yin, Y., & Li, P. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.156119 · Cited by 12
Cholinesterase inhibitors for vascular dementia and other vascular cognitive impairments: a network meta-analysis
Battle, C. E., Abdul‐Rahim, A. H., Shenkin, S. D., Hewitt, J., & Quinn, T. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013306 · Cited by 12
Vascular cognitive impairment
Pedelty, L., & Nyenhuis, D. L. (2006) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-006-0018-6 · Cited by 12
Supporting self-management in early dementia: a contribution towards ‘living well’?
Cheffey, J., Hill, L., Roberts, G. A., & Marlow, R. (2013) · Advances in Psychiatric Treatment · doi:10.1192/apt.bp.112.011023 · Cited by 12
Expression of long non‑coding RNA and mRNA in the hippocampus of mice with type 2 diabetes
Ci, L., Liu, D., Yang, J., Liu, Y., Li, C., Zhang, X., Ma, C., & Hu, R. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.9504 · Cited by 12
Vascular Cognitive Impairment
Alladi, S. (2015) · International Journal of Stroke · doi:10.1111/ijs.12634_4 · Cited by 12
Vascular dementia: a pragmatic review
Series, H. G., & Esiri, M. M. (2012) · Advances in Psychiatric Treatment · doi:10.1192/apt.bp.110.008888 · Cited by 13
Managing the Patient with Dementia in Long-Term Care
Rhodes‐Kropf, J., Cheng, H. Y., Castillo, E. H., & Fulton, A. T. (2011) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2011.01.001 · Cited by 11
Mise au point sur les démences vasculaires
Auriacombe, S., Amarenco, P., Baron, J., Ceccaldi, M. P., Dartigues, J., Lehéricy, S., Hénon, H., Hinaut, P., & Orgogozo, J. (2008) · Revue Neurologique · doi:10.1016/j.neurol.2007.06.001 · Cited by 10
Toll-like Receptor 2: A Novel Therapeutic Target for Ischemic White Matter Injury and Oligodendrocyte Death
Choi, J. Y., & Kim, B. G. (2017) · Experimental Neurobiology · doi:10.5607/en.2017.26.4.186 · Cited by 9
7, 8-dihydroxyflavone Ameliorates Cholinergic Dysfunction, Inflammation, Oxidative Stress, and Apoptosis in a Rat Model of Vascular Dementia
Dhaliwal, N., Dhaliwal, J., & Chopra, K. (2024) · Neurochemical Research · doi:10.1007/s11064-023-04090-9 · Cited by 10
Demência vascular Critérios diagnósticos e exames complementares
Engelhardt, E., Tocque, C., André, C., Moreira, D. M., Okamoto, I. H., & Cavalcanti, J. L. D. S. (2011) · Redalyc (Universidad Autónoma del Estado de México) · Cited by 8
Cholinesterase inhibitors: in search of cholinergic deficits
Overshott, R., & Burns, A. S. (2005) · Advances in Psychiatric Treatment · doi:10.1192/apt.11.5.321 · Cited by 8
Rare and unusual dementias
Gupta, S., Fiertag, O., & Warner, J. P. (2009) · Advances in Psychiatric Treatment · doi:10.1192/apt.bp.107.003558 · Cited by 11
CNS-active drugs in aging population at high risk of cerebrovascular events: Evidence from preclinical and clinical studies
Zhao, C., Hartikainen, S. A., Schallert, T. J., Sivenius, J., & Jolkkonen, J. (2007) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2007.05.003 · Cited by 8
Factors Associated with Cognitive Decline in Transient Ischemic Attack Patients
Sivakumar, L., Camicioli, R. M., & Butcher, K. (2014) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100017248 · Cited by 8
Hyperbaric oxygen therapy for vascular dementia
Xiao, Y., Wang, J., Jiang, S., & Luo, H. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009425 · Cited by 7
Evaluation of vascular cognitive impairment and identification of imaging markers using machine learning: a multimodal MRI study
He, H., Lu, D., Peng, S., Jiang, J. C., Fan, F., Sun, D. B., Sun, T., Xu, Z., Zhang, P., Peng, X., et al. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2025.1505739 · Cited by 6
Drug use in the elderly: risk or protection?
Cornelius, C. (2004) · Current Opinion in Psychiatry · doi:10.1097/00001504-200411000-00004 · Cited by 6
"Estudo comparativo do desempenho em testes neuropsicológicos de pacientes com diagnóstico de doença de Alzheimer e demência vascular"
Matioli, M. N. P. D. S. (2005) · doi:10.11606/d.5.2005.tde-01022006-212034 · Cited by 5
Molecular Hydrogen Modulates T Cell Differentiation and Enhances Neuro-Regeneration in a Vascular Dementia Mouse Model
Lee, D., Jo, H., & Choi, J. (2025) · Antioxidants · doi:10.3390/antiox14010111 · Cited by 5
Manual acupuncture enhanced therapeutic efficacy in vascular dementia rat model: systematic review and network meta-analysis
Song, Y., Chen, Y., Li, J., Sun, W., & Jin, F. (2025) · Systematic Reviews · doi:10.1186/s13643-025-02821-3 · Cited by 5
Pharmacological treatment of non-Alzheimer dementias
Arlt, S., & Jahn, H. (2006) · Current Opinion in Psychiatry · doi:10.1097/01.yco.0000245755.21621.80 · Cited by 5
Cognitive Impairment and Carotid Atherosclerosis in a General Italian Midlife and Old Population
Prati, P., Casaroli, M., Bignamini, A., Scotti, S., Canciani, L., Ruscio, M., Balestrieri, M., Bornstein, N. M., Zanetti, O. O., Tosetto, A., et al. (2006) · Neuroepidemiology · doi:10.1159/000094234 · Cited by 5
Updates in Vascular Dementia
Eizaguirre, N. O., Rementería, G. P., Torres, M. Á. G., & Gaviria, M. (2017) · Heart and Mind · doi:10.4103/hm.hm_4_16 · Cited by 5
Neurorehabilitation of poststroke cognitive impairments with the use of computed programs
Prokopenko, S. V., Mozheyko, E. Y., Koryagina, T. D., Петрова, М. М., Kaskaeva, D. S., Черных, Т. В., & Arakchaa, É. M. (2011) · International Conference on Virtual Rehabilitation · doi:10.1109/icvr.2011.5971851 · Cited by 4
Cerebralcare Granule® combined with nimodipine improves cognitive impairment in bilateral carotid artery occlusion rats by reducing lipocalin-2
Zhang, X., Jing, S., Qiao, O., Han, X., Wang, W.-Z., Ji, H., Zhang, Y., Li, X., Wang, J., Man, S., et al. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.120048 · Cited by 4
Chronic cerebrovascular diseases: pathogenetic mechanisms, clinical manifestations, and approaches to therapy
Пизова, Н. В. (2018) · Neurology neuropsychiatry Psychosomatics · doi:10.14412/2074-2711-2018-1-83-89 · Cited by 4
Management of patients with demension: holinergic deficiency and its correction
Борисовна, Л. А. (2018) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2018-12-30-35 · Cited by 4
Therapy of vascular dementia: perspectives and milestones
Moretti, R., Torre, P., Antonello, R. M., & Cazzato, G. (2005) · Therapy · doi:10.1586/14750708.2.4.649 · Cited by 4
Vascular Cognitive Impairment
Moorhouse, P. A., & Rockwood, K. J. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-6231-8.10055-8 · Cited by 5
Self-citation
4. Diagnosing Dementia: Epidemiological and Clinical Data as Cultural Text
Graham, J. (2020) · Rutgers University Press eBooks · doi:10.36019/9780813539270-006 · Cited by 4
A plea for the elective inclusion of the brain in routine whole-body FDG PET
Belhocine, T., Weiner, S. M., Brink, I., Deyn, P. P. D., Roland, J., der Borght, T. V., & Flamen, P. (2005) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-004-1729-0 · Cited by 4
Semaglutide to remodel mitochondrial dynamics and mitophagy balance for vascular dementia therapy
Yang, X., Feng, P., Zhu, H., Wang, M., Li, N., Bai, B., Sun, Y., Yan, Z., Wei, W., Chang, J., et al. (2025) · Open Research (University of Surrey) · doi:10.1002/viw.20250013 · Cited by 3
Poststroke Cognitive Decline: Is Functional Connectivity the Key to Tangible Therapeutic Targets?
Dallasta, I., & Marsh, E. B. (2024) · Stroke · doi:10.1161/strokeaha.123.044290 · Cited by 3
Testing Van Gool’s Hypothesis: A Method to Predict Side Effects of Cholinesterase Inhibitors in Patients with Cellular Degenerative and Vascular Dementia
van Eijk, L., Groot, E. R., van Spronsen, M., Maas, Y. J., Keeser, D., Pogarell, O. M., & Engelbregt, H. (2015) · Advances in Geriatrics · doi:10.1155/2015/270657 · Cited by 3
EVALUATION OF THE EFFECT OF VIGNA RADIATA LINN ON SCOPOLAMINE INDUCED WORKING AND MEMORY DEFICITS IN MICE BY USING DIFFERENT MODELS
Bhandurge, A. P., Kshirsagar, S. N., & Pratapwar, A. S. (2012) · International Journal of Research in Ayurveda and Pharmacy · doi:10.7897/2277-4343.03530 · Cited by 3
Use of escitalopram to prevent depression and cognitive impairments in the acute phase of stroke
Khasanova, D. R., & Zhitkova, Y. V. (2013) · Neurology neuropsychiatry Psychosomatics · doi:10.14412/2074-2711-2013-2354 · Cited by 3
Pharmacotherapy of Aphasia
Beversdorf, D. Q. (2007) · Journal of Head Trauma Rehabilitation · doi:10.1097/00001199-200701000-00008 · Cited by 3
Vascular and neurodegenerative cognitive impairments: a clinical case report
Zakharov, V. V., & Васильевна, В. Н. (2016) · Neurology neuropsychiatry Psychosomatics · doi:10.14412/2074-2711-2016-2-55-61 · Cited by 3
The key areas of medical therapy for ischemic stroke
Fonyakin, A. V., & Гераскина, Л. А. (2013) · Neurology neuropsychiatry Psychosomatics · doi:10.14412/2074-2711-2013-2416 · Cited by 2
Cholinesterase inhibitors in dementias
Mecocci, P., Paolacci, L., & Boccardi, V. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-815854-8.00029-x
Psychosocial Interventions in Dementia
Kiridoshi, A. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108594714.019 · Cited by 2
Review of Treatment for Late-Life Depression
Hay, K., Stageman, W., & Allan, C. L. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108594714.021 · Cited by 2
Morbus Binswanger und andere vaskuläre Demenzen
Haberl, R. L. (2011) · Springer eBooks · doi:10.1007/978-3-642-19795-6_6 · Cited by 1
Dabigatran experience in primary and secondary prevention of cardioembolic stroke
Домашенко, М. А., Maksimova, M. Y., Коробкова, Д. З., & Гафарова, М. Э. (2013) · Neurology neuropsychiatry Psychosomatics · doi:10.14412/2074-2711-2013-2417 · Cited by 1
Study of clinical risk factors and predictors of post stroke vascular cognitive impairment
Sejwar, D. A., Krishna, D. G., Dhiran, D. A., & Dubey, D. T. N. (2018) · International Journal of Medical Research and Review · doi:10.17511/ijmrr.2018.i03.01 · Cited by 1
Cerebrovascular Disease in Hypertension
Chapman, N., Arima, H., Chalmers, J. P., & Anderson, C. S. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-2766-1.00034-x · Cited by 1
A multimodal approach in the treatment of chronic cerebral ischemia: what should a doctor know?
Пизова, Н. В. (2020) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2020-4-66-73 · Cited by 1
Vascular Brain Disease in Geriatric Neuropsychiatry
Alves, G. S., & Sudo, F. K. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.101181 · Cited by 1
Management
Larner, A. J. (2018) · Springer eBooks · doi:10.1007/978-3-319-75259-4_10 · Cited by 1
Cholinesterase Inhibitors
Kao, J. S., & Grossberg, G. T. (2007) · Springer eBooks · doi:10.1007/7355_2007_012 · Cited by 1
Neurofeedback na Reabilitação Neuropsicológica Pós-Acidente Vascular Cerebral
Muratori, M. F. P., & Muratori, T. M. P. (2001) · Revista Neurociências · doi:10.34024/rnc.2012.v20.8255 · Cited by 1
Possibilities of drug therapy for vascular cognitive impairment: a critical view and possible compromises
Emelin, А. Y., & Lobzin, V. Y. (2020) · Neurology neuropsychiatry Psychosomatics · doi:10.14412/2074-2711-2020-4-131-136 · Cited by 1
Clinical Topics in Old Age Psychiatry
Lilford, P., Adshead, G., & Hughes, J. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108594714 · Cited by 1
The role of association between the cholinergic precursor choline alphoscerate and sulodexide in vascular dementia
Salvo, A. D. (2022) · Geriatric Care · doi:10.4081/gc.2021.9891 · Cited by 1
What Can Person-Centred Care in Dementia Learn from the Recovery Movement?
Hill, L., Roberts, G. A., & Perkins, R. E. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108594714.018 · Cited by 1
Donepezil in Vascular Dementia
Paci, C., Mascio, R. D., Gobbato, R., Carboni, T., Sanguigni, S., Sobrini, S., Urbano, V., Olivieri, F., & Curatola, L. (2005) · Clinical Drug Investigation · doi:10.2165/00044011-200525040-00007 · Cited by 1
A retrospective study of cholinesterase inhibitors for Alzheimer's disease : the effect of cerebrovascular disease on patient outcomes and the impact of biases on the results
Charbonneau, C. (2010) · doi:10.71781/27198 · Cited by 1
Cerebrovascular Disease in Hypertension
Chapman, N., Anderson, C. S., & Chalmers, J. P. (2007) · Elsevier eBooks · doi:10.1016/b978-1-4160-3053-9.50039-1 · Cited by 1
Dysfunctional vascular smooth muscle cells mediate early and late-stage neuroinflammation and Tau hyperphosphorylationPreprint
Aguilar-Pineda, J. A., Vera-López, K. J., Shrivastava, P., Nieto-Montesinos, R., Chávez‐Fumagalli, M. Á., Dávila-Del-Carpio, G., Valdez, B. G., Miller, C. L., Malhotra, R. K., Lindsay, M. E., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.04.13.439741 · Cited by 1
Vascular Dementia
Cagnin, A., & Battistin, L. (2007) · Springer eBooks · doi:10.1007/978-0-387-30377-2_14 · Cited by 2
The impact of simvastatin vs. atorvastatin on cognitive function in obese hypertensives
Зуева, И. Б., Игоревна, В. К., & Sanez, E. L. (2012) · Arterial’naya Gipertenziya (Arterial Hypertension) · doi:10.18705/1607-419x-2012-18-3-228-234
Dementia Treatment: Let the Evidence Lead us
Demaerschalk, B. M., Woodruff, B. K., & Caselli, R. J. (2007) · Wiley eBooks · doi:10.1002/9780470988350.ch19
Pharmacological treatment of psychosis and depression in neurological disease in older adults
Rapoport, M. J., Brown, C., & Ritchie, C. W. (2008) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544392.014
Cerebrovascular disease: vascular dementia and vascular cognitive impairment
Larner, A. J. (2008) · Cambridge University Press eBooks · doi:10.1017/cbo9780511545009.004
Vascular Development, Stroke and Neurodegenerative Disease: A Place for Novel Clinical Interventions?
Arboix, A., Grau-Olivares, M., & Krupiński, J. (2010) · Springer eBooks · doi:10.1007/978-90-481-9495-7_14
Treatment of vascular dementia: Evidence from epidemiologic studies
Bae, H., & Pandey, D. K. (2005) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-005-0050-y
Differences of TC-99M HMPAO spect imaging in the early stage of subcortical vascular dementia compared with Alzheimer's disease
Park, K. W., Jeon, S., Kim, S. R., Choi, S., Kim, S. W., Lee, S. C., Joo, H., Yoon, S. M., Jeong, J.-K., & Jang, C. W. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.02.275
Treatment of Motor and Cognitive Disorders in Patients during the Residual Period of Stroke
Агафонов, Б. В., Podrezova, L. A., Karavashkina, E. A., Вишнякова, Т. И., Смирнова, Л. А., Дадашева, М. Н., & Шевцова, Н. Н. (2011) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-011-9509-3
for Healthcare Professionals From the American Heart Association/American Vascular Contributions to Cognitive Impairment and Dementia : A Statement
Nilsson, P. M., Román, G. C., Sellke, F. W., Seshadri, S. S., Arnett, K., Bennett, D. A., Chui, H. C., Higashida, R. T., Lindquist, R. D., Nyenhuis, D. L., et al. (2011)
Association Healthcare Professionals From the American Heart Association/American Stroke Vascular Contributions to Cognitive Impairment and Dementia : A Statement for
Chui, H. C., Higashida, R. T., Lindquist, R. D., Nilsson, P. M., Petersen, C., Schneider, J. A., Tzourio, C., Arnett, D. K., Launer, L. J., Laurent, S., et al. (2013)
El uso de la embrioscopia en la pérdida gestacional recurrente
Sánez, H. A. M., Sánez, E. M., Arroyo, L. H., Ricarte, E. L. S., & Altamirano, J. M. (2013) · Revista Mexicana de Medicina de la Reproducción
Vascular Dementia
Roach, E. S., Bettermann, K., & Biller, J. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9781139644235.018
Estudo comparativo do desempenho em testes neuropsicológicos de pacientes com diagnóstico de doença de Alzheimer e demência vascular
Caramelli, P. (2005)
Imaging Dementing Illnesses
Huckman, M. S. (2006) · The Neuroradiology Journal · doi:10.1177/197140090601900405
Descripción de síntomas neuropsiquiátricos en pacientes con demencia vascular severa.
Sociales, F. D. C., & de Psicología, C. (2005)
Differences of Tc-99m HMPAO SPECT Imaging in the Early Stage of Subcortical Vascular Dementia Compared with Alzheimer's Disease
Park, K. W., Kang, D., Min-jeong, P., Cheon, S., Cha, J., Kim, S.-H., & Kim, J. W. (2007) · Nuclear Medicine and Molecular Imaging
Alzheimer’s Disease—is it Caused by Cerebrovascular Dysfunction?
Humpel, C. (2009) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195326697.003.0015
Effects of a Cardiotonic Medicine, Danshen Pills, on Cognitive Ability and Expression of PSD-95 in a Vascular Dementia Rat Model
Zhu, Y., Zeng, Y., He, C., Jiang, S., Zhou, L., Huang, Y.-M., Qiang, C., & Jiang, Y. (2016) · Neurophysiology · doi:10.1007/s11062-016-9598-2
Therapy of poststroke cognitive impairment
Emelin, А. Y. (2016) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2016-17-38-41
A Study on Clinical Determinants and one year Follow-Up of Dementia and Mild Cognitive Impairment Following Ischemic Stroke
Nagarajan, M. (2017) · Journal of Medical Science And clinical Research · doi:10.18535/jmscr/v5i10.180
Mental Health Laws from All UK Jurisdictions
Burrell, C., & Emmett, C. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108594714.024
Epidemiology and Mental Health in Old Age
Lilford, P., & Hughes, J. C. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108594714.004
Mental Health in Parkinson’s Disease
Jones, S., Torsney, K., Scourfield, L., Berryman, K., & Henderson, E. J. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108594714.011
Mini-Mental State Examination for the Detection and Prediction of Dementia in People with and without Mild Cognitive Impairment
Mitchell, A. J. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108594714.014
Residence Capacity
Hughes, J. C., Poole, M., Louw, S., Greener, H., & Emmett, C. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108594714.026
Concluding Reflections
Lilford, P. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108594714.028
Vascular Dementia
Series, H. G., & Esiri, M. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108594714.005
Introductory Comments
Hughes, J. C. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108594714.003
Supporting Self-Management in Early Dementia
Cheffey, J., Hill, L., & Roberts, G. A. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108594714.017

Authors: Erkinjuntti, T., Román, G., Gauthier, S., Feldman, H., & Rockwood, K.
Affiliations: Dalhousie University (CA)
From Helsinki University Central Hospital, Helsinki, Finland (T.E.); University of Texas Health Science Center at San Antonio and A. Murphy Veterans Administration Hospital, San Antonio, Tex (G.R.); Alzheimer’s Disease Research Unit, McGill Centre for Studies on Aging, Montreal, Quebec, Canada (S.G.); Division of Neurology, University of British Columbia, Vancouver, British Columbia, Canada (H.F.); and Queen Elizabeth II Health Science Centre, Geriatric Medicine Research Unit, Dalhousie University,...
ORCID: Erkinjuntti, Timo
Gauthier, Serge
Feldman, Howard
Rockwood, Kenneth
Venue: Stroke
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2004-04
Volume: 35
Issue: 4
Pages: 1010-1017
ISSN: 0039-2499 (ISSN-L)
1524-4628
DOI: 10.1161/01.str.0000120731.88236.33
OpenAlex: W2167597327
Cited by: 232
References: 85
Citations by year: 2026: 1 · 2025: 6 · 2024: 3 · 2023: 3 · 2022: 4 · 2021: 10 · 2020: 38 · 2019: 5 · 2018: 8 · 2017: 7 · 2016: 11 · 2015: 8 · 2014: 5 · 2013: 10 · 2012: 9
FWCI: 13.17
Type: journal article
Language: en
Open access: closed
Locations: Stroke (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
Life Sciences › Neuroscience › Neurology › Neuroprotection in Cerebral Ischemia
Keywords: vascular dementia, vascular cognitive impairment, cholinesterase inhibitors, donepezil, galantamine, memantine, NMDA receptor antagonists, Alzheimer's disease, cerebrovascular disease, stroke prevention, hypertension, hyperlipidemia, cholinergic deficit, dementia prevention
MeSH terms: Rivastigmine, Donepezil, Carbamates, Cardiovascular Diseases, Cerebrovascular Disorders, Cholinesterase Inhibitors, Cognition Disorders, Galantamine, Humans, Indans, Terminology as Topic, Piperidines, Risk Factors, Dementia, Vascular, Controlled Clinical Trials as Topic, Stroke, Phenylcarbamates

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Emerging Therapies for Vascular Dementia and Vascular Cognitive Impairment

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks